D. Glenn Steele's most recent trade in PTC Therapeutics Inc was a trade of 8,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 8,800 | 8,800 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 4,000 | 18,500 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | D. Glenn Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 4,000 | 14,500 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 4,000 | 10,500 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 12,000 | 12,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 3,200 | 6,500 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 10,000 | 10,000 | - | - | Stock Option (Right To Buy) | |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 1,650 | 3,300 (0%) | 0% | 0 | Common Stock |